CVE-2023-33365
Severity Score
7.5
*CVSS v3.1
Exploit Likelihood
*EPSS
Affected Versions
*CPE
Public Exploits
0
*Multiple Sources
Exploited in Wild
-
*KEV
Decision
Attend
*SSVC
Descriptions
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
*Credits:
N/A
CVSS Scores
Attack Vector
Attack Complexity
Privileges Required
User Interaction
Scope
Confidentiality
Integrity
Availability
Attack Vector
Attack Complexity
Authentication
Confidentiality
Integrity
Availability
* Common Vulnerability Scoring System
SSVC
- Decision:Attend
Exploitation
Automatable
Tech. Impact
* Organization's Worst-case Scenario
Timeline
- 2023-05-22 CVE Reserved
- 2023-08-03 CVE Published
- 2024-10-17 CVE Updated
- 2025-01-13 EPSS Updated
- ---------- Exploited in Wild
- ---------- KEV Due Date
- ---------- First Exploit
CWE
- CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
CAPEC
References (2)
| URL | Tag | Source |
|---|---|---|
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33365 | Third Party Advisory |
| URL | Date | SRC |
|---|
| URL | Date | SRC |
|---|
| URL | Date | SRC |
|---|---|---|
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | 2023-08-09 |
Affected Vendors, Products, and Versions
| Vendor | Product | Version | Other | Status | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Vendor | Product | Version | Other | Status | <-- --> | Vendor | Product | Version | Other | Status |
| Supremainc Search vendor "Supremainc" | Biostar 2 Search vendor "Supremainc" for product "Biostar 2" | < 2.9.1 Search vendor "Supremainc" for product "Biostar 2" and version " < 2.9.1" | - |
Affected
| ||||||